Table 1

Patient Characteristics by 25-OH Vitamin D Levels
All N = 104 Deficient (<20 ng/ ml) N = 35 Not Deficient N = 69 p-value*
Variable X (1SD) or n (%) X (1SD) or n (%) X (1SD) or n (%)
Demographics
Age 15.38 ± 1.6 15.28 ±  1.63 15.43 ±  1.60 0.66
Sex (M/F) (%Male) 29/75 (27.9) 11/24 (31.4) 18/51 (27.9) 0.57
Race (White/Black/Hispanic/ Asian/Biracial) (%White) 76/15/1/5/7 (73.1) 17/9/0/5/4 (50.0) 59/6/1/0/3 (67.0) 0.0003
Residence (Urban/ Suburban or Rural) (%Urban) 10/94 (9.6) 3/32 (8.6) 7/62 (6.7) 0.80
Insurance (Private/ Medicaid) (%Private) 65/39 (62.5) 19/16 (54.3) 46/23 (66.7) 0.22
Smoking Status (Yes/No) (%Yes) 18/67 (21.2) 9/20 (31) 9/47 (16.1) 0.11
Inpatient or Outpatient Status (Inpatient/ Outpatient) (% Inpatient) 34/70 (32.7) 14/21 (40) 20/49 (29.0) 0.26
Metabolic Variables
Body Mass Index (BMI) 25.2 ± 7.6 26.1 ± 8.4 24.7 ± 7.2 0.39
Glucose 93.9 ± 18.1 91.7 ± 13.8 94.9 ± 19.7 0.42
Cholesterol, total 167.4 ± 34.4 167.6 ± 30.8 167.3 + 36.7 0.98
High Density Lipoprotein (HDL) 53.1 ± 13.9 54.3 ± 13.5 52.4 ± 14.3 0.63
Low Density Lipoprotein (LDL) 94.0 ± 25.0 95.7 ± 21.9 93.0 ± 26.8 0.71
Triglycerides 96.0 ± 69.3 87.6 ± 57.6 100.5 ± 75.2 0.52
Pulse 79.6 ± 15.6 78.4 ± 12.4 80.3 ± 16.7 0.57
Diastolic Blood Pressure 67.6 ± 9.0 69.1 ± 9.3 66.7 ± 8.7 0.20
Systolic Blood Pressure 115.3 ± 12.7 116.9 ± 14.3 114.5 ± 11.9 0.39
Illness Features and Family History
Psychosis N, (%) 25 (24.0) 14 (40.0) 11 (15.9) 0.007
Immediate Family Psychosis N, (%) 10 (9.6) 4 (11.4) 6 (8.7) 0.66
Extended Family Psychosis N, (%) 10 (9.6) 5 (14.3) 5 (7.3) 0.25
Illness Age of Onset (Prepubertal/ Adolescent) (% Prepubertal) 45/55 (45) 14 (41.2) 31 (47.0) 0.69
DSM-IV diagnoses, N (%)
Bipolar Disorders 37 (36) 13 (37) 24 (34.8) 0.81
Unipolar Depressive 36 (35) 9 (25.7) 27 (39.1) 0.17
Mood Disorder NOS 15 (14) 6 (17.1) 9 (13.0) 0.57
Anxiety Disorder NOS 5 (5) 2 (5.7) 3 (4.3) 0.76
Psychotic Disorder NOS 8 (7.7) 5 (14.3) 3 (4.3) 0.07
Other (Yes/No) (%Yes) 3 (1.3) 0 (0.0) 3 (4.3) 0.21
Current Medication Exposure, N (%)
Stimulants N, (%) 6 (5.8) 2(5.7) 4 (5.8) 0.99
Antidepressants N, (%) 44 (42.3) 11 (31.4) 33 (47.8) 0.11
Antipsychotics N, (%) 35 (33.7) 12 (34.3) 23 (66.7) 0.92
Anticonvulsants N, (%) 18 (17.3) 5 (14.9)) 13 (18.8) 0.56
Benzodiazepines N, (%) 6 (5.8) 3 (8.6) 3 (4.35) 0.38
Other medications 31 (29.8) 8 (22.9) 23 (33.3) 0.27
Past Medication Exposure, N (%)
Stimulants N, (%) 18 (17.3) 7 (20.0) 11 (15.9) 0.60
Antidepressants N, (%) 42 (40.4) 12 (34.3) 30 (56.5) 0.37
Antipsychotics N, (%) 21 (20.2) 6 (17.1) 15 (21.7) 0.58
Anticonvulsants N, (%) 20 (19.2) 4 (11.4) 16 (23.2) 0.15
Benzodiazepines N, (%) 3 (2.88) 0 (0.0) 3 (4.35) 0.21
Other medications 9 (8.7) 2 (5.7) 7 (10.1) 0.4

*Evaluated by ANOVA, Wilcoxon rank sum test, χ², or Fisher’s exact test.

Missing data were present for the following (N): BMI, 4;, glucose 5; cholesterol and HDL 50; LDL 49;

TG 49, pulse 4, DBP and SBP 5; calcium 6; height 4; waist circumference 50; weight 3.

Gracious et al.

Gracious et al. BMC Psychiatry 2012 12:38   doi:10.1186/1471-244X-12-38

Open Data